Ranger Investment Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-776,428
Closed -$9.43M 106
2022
Q1
$9.43M Buy
776,428
+20,048
+3% +$422K 0.6% 51
2021
Q4
$25.8M Sell
756,380
-54,576
-7% -$2.14M 1.41% 31
2021
Q3
$39.1M Sell
810,956
-21,330
-3% -$987K 2.09% 15
2021
Q2
$37.6M Sell
832,286
-19,381
-2% -$859K 1.96% 19
2021
Q1
$41.1M Sell
851,667
-89,768
-10% -$4.67M 2.26% 13
2020
Q4
$50.7M Sell
941,435
-325,520
-26% -$14.7M 2.67% 9
2020
Q3
$46.7M Sell
1,266,955
-10,642
-0.8% -$396K 2.97% 5
2020
Q2
$39.6M Buy
1,277,597
+386,329
+43% +$10.7M 2.71% 9
2020
Q1
$24.6M Sell
891,268
-298,897
-25% -$8.95M 2.16% 17
2019
Q4
$34.8M Buy
1,190,165
+58,271
+5% +$1.39M 2.3% 13
2019
Q3
$21.6M Sell
1,131,894
-76,726
-6% -$1.8M 1.55% 30
2019
Q2
$26.5M Sell
1,208,620
-915
-0.1% -$20.1K 1.81% 17
2019
Q1
$24.7M Sell
1,209,535
-216,185
-15% -$3.76M 1.79% 21
2018
Q4
$18M Buy
1,425,720
+203,085
+17% +$3.03M 1.47% 31
2018
Q3
$18.8M Buy
1,222,635
+1,048,405
+602% +$14.5M 1.24% 37
2018
Q2
$2.28M Sell
174,230
-30,585
-15% -$337K 0.16% 72
2018
Q1
$1.67M Buy
204,815
+40,505
+25% +$328K 0.12% 69
2017
Q4
$1.46M Buy
164,310
+10,700
+7% +$98.7K 0.11% 69
2017
Q3
$1.71M Buy
+153,610
New +$1.5M 0.13% 67

Other funds holding NEO

Ranger Investment Management's NEO Position: Q2 2022 in Review

Ranger Investment Management sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 776,428 shares — an estimated $9.43M sold.

Ranger Investment Management first reported a position in NEO in Q3 2017 and held it in 19 quarters. The position peaked at $50.7M in Q4 2020. 240 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

  • Ranger Investment Management reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
  • Ranger Investment Management sold 776,428 NeoGenomics shares in Q2 2022, an estimated $9.43M.
  • Ranger Investment Management first reported a position in NeoGenomics in Q3 2017 and held it in 19 quarters.
  • Ranger Investment Management's NeoGenomics position peaked at $50.7M in Q4 2020.
  • 240 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Ranger Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.